SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Denver, CO.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is trending due to a mix of earnings results and news of Michael Burry's significant short position against the stock, sparking debates about valuation and future growth potential. Community discussions revolve around whether the company is overvalued, with some defending its AI capabilities and government contracts, while others point to its high P/E ratio and the potential impact of Burry's bet.

SSgA Active Trust - SPDR S&P 500 ETF Trust

The SPY is seeing increased discussion around a potential market correction, with community members pointing to AI overvaluation and heavy leveraging as potential catalysts for a significant pullback. Traders are actively debating whether this dip is a buying opportunity or the start of a longer-term bearish trend, as they watch key support levels. The conversation also includes concerns about political and economic factors influencing market direction.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is trending amid discussions about its recent earnings and the impact of COVID-era data on trial results for PMO therapies; while some express concern over missed statistical significance, others highlight the revenue beat and potential for Elevidys to replace older treatments. The community is debating the likelihood of FDA action on PMO drugs and the company's overall valuation in light of recent events, with some suggesting a buyout opportunity.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

HIMS is trending amid mixed sentiment heading into earnings, with discussions around a potential deal with Novo Nordisk for weight-loss drugs like Wegovy. The community is closely watching subscriber growth and margin expansion, while analysts debate the impact of increased competition and past concerns regarding GLP-1s. Some traders are betting on a post-earnings squeeze, while others point to technical indicators suggesting further downside.

Internet Computer (IC) is the world’s first blockchain that is capable of running at web speed at unrestrictive capacities. Built by the DFINITY Foundation, IC aims to recreate the web by supporting smart contract development at scale and changing the way people can interact using web services. Internet Computer aims to extend the public internet, so that it can be the world’s computing platform, in a decentralized manner. Internet Computer sets to revolutionalize the design of the crypto economy, with an aim to overhaul traditional software services.   The project was founded in October 2016 by Dominic WIllams and have raised a total of $121 million from investors such as Adreessen Horowitz, Polychain Capital, Multicoin Capital and such. On May 10, 2021, DFINITY launched the Internet Computer into the public domain, marking it a major milestone for ICP as it means the internet now functions as a decentralised global computer. This is marked by the release of all of the Internet Computer’s source code into the public domain, as well as ICP utility token that allows tens of thousands of community members to govern the Internet Computer network.  ICP is Internet Computer's native token. It plays three prominent roles:  1. Network Governance: Users that participate in the governance will be rewarded with ICPI 2. Production of Cycles for Compute: ICP can be converted into cycles where it is used as the transaction fee to access the network. Cycles are burned after used. 3. Rewarding Users: ICP is used as the rewards to incentivize users to participate in the network such as securing the network.

Internet Computer

Internet Computer (ICP) is trending amid community discussion around its recent price movements and potential. Some traders highlight its relative strength as Bitcoin and other cryptos decline, while others remain skeptical, citing its past performance. Discussions include its technology, future potential, and the impact of upcoming announcements.

Zcash is a decentralized and open-source cryptocurrency that offers privacy and selective transparency of transactions. Zcash payments are published on a public blockchain, but the sender, recipient, and amount of a transaction remain private.  Zcash is based on peer-reviewed cryptographic research, and built by a security-specialized engineering team on an open source platform based on Bitcoin Core's battle-tested codebase. Our improvement over Bitcoin is the addition of privacy. Zcash uses advanced cryptographic techniques, namely zero-knowledge proofs, to guarantee the validity of transactions without revealing additional information about them.  How Zcash works  Zcash encrypts the contents of shielded transactions. Since the payment information is encrypted, the protocol uses a novel cryptographic method to verify their validity.  Zcash uses a zero-knowledge proof construction called a zk-SNARK, developed by our team of experienced cryptographers based on recent breakthroughs in cryptography. These constructions allow the network to maintain a secure ledger of balances without disclosing the parties or amounts involved. Instead of publicly demonstrating spend-authority and transaction values, the transaction metadata is encrypted and zk-SNARKs are used to prove that nobody is cheating or stealing.  Zcash also enables users to send public payments which work similarly to Bitcoin. With the support for both shielded and transparent addresses, users can choose to send Zcash privately or publicly. Zcash payments sent from a shielded address to a transparent address reveal the received balance, while payments from a transparent address to a shielded address protect the receiving value.   Check out CoinBureau for guide on What is ZCash.

Zcash

Zcash is trending as traders discuss its potential as 'the better Bitcoin' due to its privacy features and limited supply, with some community members speculating about a short squeeze and a rapid price surge to $1,000.  The conversation also highlights ZEC as a hedge against Bitcoin's volatility, with some suggesting a rotation from BTC into ZEC.  Mentions of its upcoming anniversary and bullish technical indicators add to the current hype.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

META is trending due to a post-earnings selloff, with the community debating whether the drop is an overreaction or a sign of deeper issues related to AI spending and future profitability. Sentiment is mixed, ranging from calls to buy the dip to concerns about technicals and potential further declines. Some traders are pointing to historical patterns and oversold conditions as potential catalysts for a bounce.

Welcome to SLAP – The Only Coin That Slaps Harder Than Your Moms  Tired of coins that claim they SLAP but are nothing but limp wrists? SLAP is here to SLAP some sense into the crypto space.  Founded by the Flutter of Five Fingers and powered by the Prancing of the Pried Palm, SLAP isn’t just another coin—it’s an attitude.  We’re not here to talk roadmaps, utility, or world peace. We’re here to SLAP charts, SLAP the haters, and SLAP our way to the top. No VC suits, no corporate nonsense—just raw, unfiltered internet culture with a side of “did we just do that?  ”So load your wallet, mute your financial advisor, and get ready to ride the most unhinged meme rocket. Open up your hands, and start swingin'. You never know what you could hit.  SLAP: It’s not a coin. It’s a lifestyle.

Slap

$SLAP is gaining traction, trending as a top crypto, with community members highlighting staking options and a strong, active team. Bullish sentiment is fueled by the project's IRL events, pro athlete sponsorships, and consistent presence on multiple platforms. Discussions also revolve around the supportive community and the potential for significant growth.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending as the market navigates a mixed sentiment driven by AI optimism versus concerns about valuations and economic uncertainty. Community members are actively discussing potential overextension in tech, particularly regarding names like NVDA and PLTR, while also monitoring signals for a possible market correction. News regarding potential impacts from the government shutdown and developments in U.S.-China trade relations are adding to the complex market outlook.

Grab Holdings Ltd. engages in the provision of millions of people each day to access its driver- and merchant-partners to order food or groceries, send packages, hail a ride or taxi, pay for online purchases or access services such as lending, insurance, wealth management and telemedicine, all through a single “everyday everything” app. The firm operates in food deliveries and mobility and by TPV in the e-wallets segment of financial services in Southeast Asia. It operates across the deliveries, mobility and digital financial services sectors in eight countries namely: Cambodia, Indonesia, Malaysia, Myanmar, the Philippines, Singapore, Thailand and Vietnam. The company was founded by Anthony Tan Ping Yeow and Tan Hooi Ling in 2012 and is headquartered in Singapore.

Grab Holdings Limited - Ordinary Shares - Class A

Grab Holdings Limited

Grab ($GRAB) is trending due to increased retail investor buzz after the company raised its earnings forecast.  The community is discussing its impressive On-Demand GMV growth and raised full-year revenue guidance.  Some see Grab as an emerging fintech opportunity and a dominant player in the Southeast Asian market.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$RGBP Target $3.25-$4.50 
WHY?

RGBP has
# 1 (24+) Patents worth BILLIONS
https://patents.google.com/?inventor=David+Koos&amp;sort=new
https://patents.justia.com/assignee/regen-biopharma-inc

# 2 Licensing of (1) Patent with (2) INDs (New Drug Applications) for treating pancreatic &amp; colon cancer by mRNA Vaccine. &quot;The Future of Medicine&quot; https://www.aamc.org/news-insights/mrna-technology-promises-revolutionize-future-vaccines-and-treatments-cancer-infectious-diseases

# 3 On track with Big Pharmas aggressively developing mRNA Vaccines for treating cancer; a TRILLION $ Dollar Market
https://www.ventureradar.com/keyword/Cancer%20Vaccines

# 4 FDA Patent Approval
https://newsinvasion24.com/regen-biopharma-inc-otcmkts-rgbp-gets-approval-for-cancer-vaccine-patent/

# 5 Partnership:Oncology Pharma Paid $1 Million for Patent Licensing; RGBP will Post Quarterly Revenues for 15 years

# 6 Valuation Assessment/Certification of RGBP by Biotech Research Group will be complete on 11/15 that includes all Patents, and extends to Regulatory &amp; Commercialization matters. This is indicative of an Industry Standard Buy Out/Acquisition

# 7 CEO reveals Acquisition intent by filing an 8k on 4/27/21
https://www.otcmarkets.com/filing/conv_pdf?id=14894907&amp;guid=Gv8wkq9sKMwyvOh

# 8 OTC Bull Market run in progress with 1,400 fewer stocks

Cliff George

Judge Chamberlain Haller

FFLXPXToo

Joe P

Steve santjer

SamW

Antfill

Justin Zeigler

Philly

Cody Maclaughlin

Tamra

Debbie S.

ARREST FAUCI

Chris

Johnny

Billy Ray Valentine

Connie T.

Billy Ray

Trish

Leslie Clark

Scott Bennett

Jw1508

Jon Vera

William colcord

B. Anthony

Search and read the full text of patents from around the world with Google Patents, and find prior art in our index of non-patent literature.

Google

Google Patents

Justia - Patents - Patents and Patent Application Resources

Justia

Patents Assigned to Regen BioPharma, Inc - Justia Patents Search

The first U.S. vaccines against COVID-19 emerged from decades of university research and may portend a faster, cheaper way to combat other diseases.

AAMC

mRNA technology promises to revolutionize future vaccines and treatments for cancer, infectious diseases

Top companies for Cancer Vaccines at VentureRadar with Innovation Scores, Core Health Signals and more. Including Merck & Co., Inc. (aka MSD) etc

Ventureradar

Top Cancer Vaccines companies | VentureRadar

Regen Biopharma Inc (OTCMKTS: RGBP) had its antigen-specific mRNA cellular cancer vaccine patent approved on August 17. The announcement is to be made when the company goes pink current. Regen is a biotechnology company that focuses on immunotherapy and immunology. Currently, the company is trying to improve small molecule therapy to treat autoimmune diseases and [...]

News Invasion 24

Regen Biopharma Inc (OTCMKTS: RGBP) Gets Approval for Cancer Vaccine Patent

Otcmarkets

StockTwits Web

Regen Biopharma Inc

 Target $3.25-$4.50 
WHY?

RGBP has
# 1 (24+) Patents worth BILLIONS




# 2 Licensing of (1) Patent with (2) INDs (New Drug Applications) for treating pancreatic & colon cancer by mRNA Vaccine. "The Future of Medicine" 



# 3 On track with Big Pharmas aggressively developing mRNA Vaccines for treating cancer; a TRILLION $ Dollar Market




# 5 Partnership:Oncology Pharma Paid $1 Million for Patent Licensing; RGBP will Post Quarterly Revenues for 15 years

# 6 Valuation Assessment/Certification of RGBP by Biotech Research Group will be complete on 11/15 that includes all Patents, and extends to Regulatory & Commercialization matters. This is indicative of an Industry Standard Buy Out/Acquisition

# 7 CEO reveals Acquisition intent by filing an 8k on 4/27/21




# 8 OTC Bull Market run in progress with 1,400 fewer stocks

Ben Gikanga

@OTCShotCaller  Always nice to hear from you on a day like today!

Luchell McBride

StockTwits For Android 

  Always nice to hear from you on a day like today!

@OTCShotCaller  not likely to ever be that high

Mark

StockTwits for iOS

Midge

@Killerinthehome - F.Y.I. In an Acquisition/Merger the acquired company will trade under the Ticker of the acquiring Big Pharma at the current pps that will definitely be in the Dollar Range, possible double digits! $$ However  RGBP share holders will have fewer shares under the new Ticker but with a much higher valuation that will reflect how the Acquisition is structured. So what you&#39;re saying is not correct.

Billy

@Killerinthehome - F.Y.I. In an Acquisition/Merger the acquired company will trade under the Ticker of the acquiring Big Pharma at the current pps that will definitely be in the Dollar Range, possible double digits! $$ However  RGBP share holders will have fewer shares under the new Ticker but with a much higher valuation that will reflect how the Acquisition is structured. So what you're saying is not correct.

@OTCShotCaller   So 1/50th the shares but 100 times the share price.

   So 1/50th the shares but 100 times the share price.

 # 7 CEO reveals Acquisition intent by filing an 8k on 4/27/21

https://www.otcmarkets.com/filing/conv_pdf?id=14894907&amp;guid=2TtwkaSmWjtch3h

(this link changes daily) LOL!

 # 7 CEO reveals Acquisition intent by filing an 8k on 4/27/21



@OTCShotCaller sorry OTC. While I love the medical insight and experience you bring to the table, your market experience in regards to share structure is lacking.  
Unless regen comes out and says they&#39;ve cured cancer (which could happen down then line) this will never hit those SP targets with out an RS. The volume will never get there. (And would need to side with buying heavily).
I truly believe we&#39;ll all make good money on this but you&#39;re being unreasonable with your SP targets. 
Hope im wrong but history shows its just not possible.

Don Diesel

 sorry OTC. While I love the medical insight and experience you bring to the table, your market experience in regards to share structure is lacking.  
Unless regen comes out and says they've cured cancer (which could happen down then line) this will never hit those SP targets with out an RS. The volume will never get there. (And would need to side with buying heavily).
I truly believe we'll all make good money on this but you're being unreasonable with your SP targets. 
Hope im wrong but history shows its just not possible.